- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Five EHR Products Receive Meaningful Use Certification
Five health information technology vendors have recently received certification of specific products meeting Stage 1 electronic health records meaningful use criteria.
“Complete EHR” certification means a product supports all ambulatory or inpatient meaningful use requirements. “EHR Module” certification means an ancillary application meets one or more requirements. The recently certified products, all tested by Drummond Group, include:
* ADS Technologies’ Supra, version 4.0, as a Complete EHR;
* Virco Lab’s AVIGA for HIV/AIDS care, version 1.0, as an EHR Module;
* IOD Incorporated’s PRISM release of information software, version 6.0, as an EHR Module;
* Streamline Health’s AccessAnyWare HIM software, version 1.9, as an EHR Module; and
* Hyland Software’s OnBase HIM software, version 11.0, as an EHR Module.
Read more at: http://www.healthdatamanagement.com/news/ehr-electronic-health-records-meaningful-use-onc-43828-1.html
Source: Health Data Management
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Coexistence of HIV, Hemophilia May Lead to Increased Presence of Coronary Artery Stenosis
May 8th 2024In patients living with HIV, the cardiovascular risk factors that come with infection may lead to an increased prevalence of coronary artery stenosis, especially in those who also have hemophilia.
Read More
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Budesonide-Based Triple Therapy Shows Best Benefit Over Dual Therapy for COPD
May 8th 2024The triple therapy of budesonide, glycopyrrolate, and formoterol fumarate showed the greatest incremental net benefit among a series of triple therapy medications that were evaluated against dual therapy for chronic obstructive pulmonary disease (COPD), according to an analysis presented at ISPOR.
Read More
